• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:最重要的创新]

[ESC/EACTS guidelines on myocardial revascularization 2018 : The most important innovations].

作者信息

Neumann F-J, Hochholzer W, Siepe M

机构信息

Klinik für Kardiologie und Angiologie II, Universitäts-Herzzentrum Freiburg ∙ Bad Krozingen, Südring 15, 79189, Bad Krozingen, Deutschland.

Klinik für Herz- und Gefäßchirurgie, Universitäts-Herzzentrum Freiburg ∙ Bad Krozingen, Bad Krozingen, Deutschland.

出版信息

Herz. 2018 Dec;43(8):689-694. doi: 10.1007/s00059-018-4764-5.

DOI:10.1007/s00059-018-4764-5
PMID:30456630
Abstract

The guidelines on myocardial revascularization published in 2018 are a joint initiative of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery. To establish indications for myocardial revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), evidence of the functional relevance of coronary artery stenoses is needed either by non-invasive imaging function tests or intravascular hemodynamic measurements. The prognostic and symptomatic benefits of myocardial revascularization depend on whether complete revascularization can be achieved. This needs to be considered when choosing the most appropriate revascularization strategy. In addition, the individual operative risk, the technical feasibility, the presence of diabetes mellitus and the anatomical complexity of coronary artery disease, as assessed by the SYNTAX score, are key criteria when choosing the optimal method of revascularization. For PCI radial artery access and the general use of drug-eluting stents are recommended. For CABG multiple arterial grafts should be strived for including the radial artery for treatment of high-grade coronary stenosis.

摘要

2018年发布的心肌血运重建指南是欧洲心脏病学会和欧洲心胸外科学会的联合倡议。为了确定经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)进行心肌血运重建的适应症,需要通过非侵入性成像功能测试或血管内血流动力学测量来证明冠状动脉狭窄的功能相关性。心肌血运重建的预后和症状改善益处取决于能否实现完全血运重建。在选择最合适的血运重建策略时需要考虑这一点。此外,个体手术风险、技术可行性、糖尿病的存在以及通过SYNTAX评分评估的冠状动脉疾病的解剖复杂性,是选择最佳血运重建方法时的关键标准。对于PCI,推荐桡动脉入路和药物洗脱支架的普遍使用。对于CABG,应争取使用多条动脉移植物,包括桡动脉,用于治疗严重冠状动脉狭窄。

相似文献

1
[ESC/EACTS guidelines on myocardial revascularization 2018 : The most important innovations].[2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:最重要的创新]
Herz. 2018 Dec;43(8):689-694. doi: 10.1007/s00059-018-4764-5.
2
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.2022 年 ESC/EACTS 联合对 2018 年指南建议的回顾:低手术风险且适合 PCI 或 CABG 解剖结构的左主干冠状动脉疾病患者的血运重建。
Eur J Cardiothorac Surg. 2023 Aug 1;64(2). doi: 10.1093/ejcts/ezad286.
3
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.2022 年 ESC/EACTS 联合对 2018 年指南建议的回顾:低手术风险且适合 PCI 或 CABG 解剖结构的左主干冠状动脉疾病患者的血运重建。
Eur Heart J. 2023 Nov 1;44(41):4310-4320. doi: 10.1093/eurheartj/ehad476.
4
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组编写,欧洲经皮心血管介入协会(EAPCI)提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
5
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014 欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组。由欧洲经皮心血管介入协会(EAPCI)提供特别贡献制定。
Eur J Cardiothorac Surg. 2014 Oct;46(4):517-92. doi: 10.1093/ejcts/ezu366. Epub 2014 Aug 29.
6
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗对三血管病变患者的比较:SYNTAX 试验的最终五年随访结果。
Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21.
7
Revascularization in complex multivessel coronary artery disease after FREEDOM. Is there an indication for PCI and drug-eluting stents?FREEDOM研究后复杂多支冠状动脉疾病的血运重建。是否有PCI及药物洗脱支架的适应证?
Herz. 2016 May;41(3):224-32. doi: 10.1007/s00059-016-4418-4.
8
Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.欧洲心脏病学会和欧洲心胸外科学会指南对稳定型冠状动脉疾病血运重建策略的影响:经皮冠状动脉介入治疗和冠状动脉旁路移植术的活动变化。
J Thorac Cardiovasc Surg. 2014 Feb;147(2):606-10. doi: 10.1016/j.jtcvs.2013.01.026. Epub 2013 Feb 10.
9
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干狭窄患者的比较:系统评价和荟萃分析。
JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.
10
Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.EXCEL 试验中依维莫司洗脱支架与冠状动脉旁路移植术治疗左主干血运重建效果的长期预测和死亡率比较:SYNTAX 评分 II 的前瞻性验证。
Eur Heart J. 2015 May 21;36(20):1231-41. doi: 10.1093/eurheartj/ehu518. Epub 2015 Jan 12.

引用本文的文献

1
Bridging With Low-Molecular-Weight Heparin Versus Antiplatelet Therapy in Patients Undergoing Noncardiac Surgery After Percutaneous Coronary Intervention: A Comprehensive Review.经皮冠状动脉介入治疗后行非心脏手术患者中低分子肝素桥接与抗血小板治疗的比较:一项全面综述。
Clin Cardiol. 2024 Sep;47(9):e70008. doi: 10.1002/clc.70008.
2
Therapeutic Potential of Hydrogen Sulfide in Ischemia and Reperfusion Injury.硫化氢在缺血再灌注损伤中的治疗潜力。
Biomolecules. 2024 Jun 22;14(7):740. doi: 10.3390/biom14070740.
3
Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction.

本文引用的文献

1
Interpretation of results of pooled analysis of individual patient data - Authors' reply.个体患者数据汇总分析结果的解读——作者回复
Lancet. 2018 Sep 8;392(10150):818. doi: 10.1016/S0140-6736(18)31779-3.
2
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
3
Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization.
严重缺血性左心室功能障碍患者经皮血运重建的结果。
Curr Cardiol Rep. 2024 May;26(5):435-442. doi: 10.1007/s11886-024-02045-2. Epub 2024 Apr 20.
4
Complete revascularization based on angiography derived fractional flow reserve versus incomplete revascularization in patients with ST-segment elevation myocardial infarction.基于血管造影衍生的血流储备分数的完全血运重建与 ST 段抬高型心肌梗死患者的不完全血运重建。
Cardiol J. 2024;31(2):226-234. doi: 10.5603/cj.92762. Epub 2023 Sep 29.
5
Safety of cangrelor and transition to oral P2Y inhibitors in patients undergoing percutaneous coronary intervention: the ARCANGELO study.坎格雷洛在接受经皮冠状动脉介入治疗患者中的安全性及向口服P2Y抑制剂的转换:ARCANGELO研究
Eur Heart J Open. 2023 Aug 28;3(4):oead076. doi: 10.1093/ehjopen/oead076. eCollection 2023 Jul.
6
Prognostic Assessment of Fractional Flow Reserve in Different Strata in Patients with Coronary Artery Disease.冠心病患者不同亚组人群中血流储备分数的预后评估。
Arq Bras Cardiol. 2023 May;120(6):e20211051. doi: 10.36660/abc.20211051.
7
Self-Expanding Versus Balloon Expanding Coronary Stents in Intervention of the Degenerated Saphenous Vein Graft: Memmingen Coronary Artery Bypass Stenosis Trial (MECAST).自膨式与球囊扩张式冠状动脉支架在退行性大隐静脉桥病变介入治疗中的比较:门兴格拉德巴赫冠状动脉旁路移植狭窄试验(MECAST)。
J Interv Cardiol. 2023 Apr 6;2023:9412132. doi: 10.1155/2023/9412132. eCollection 2023.
8
Bone Marrow Culture-Derived Conditioned Medium Recovers Endothelial Function of Vascular Grafts following Ischemia/Reperfusion Injury in Diabetic Rats.骨髓培养来源的条件培养基可恢复糖尿病大鼠缺血/再灌注损伤后血管移植物的内皮功能。
Stem Cells Int. 2022 Oct 14;2022:7019088. doi: 10.1155/2022/7019088. eCollection 2022.
9
Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury.Nrf2 相关的表观遗传调控在缺血再灌注损伤中的综合概述。
Theranostics. 2022 Sep 11;12(15):6626-6645. doi: 10.7150/thno.77243. eCollection 2022.
10
A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA).无阻塞性冠状动脉缺血(INOCA)的侵入性检测实用方法。
CJC Open. 2022 May 4;4(8):709-720. doi: 10.1016/j.cjco.2022.04.009. eCollection 2022 Aug.
稳定型多支冠状动脉疾病主要类别患者选择冠状动脉旁路移植术和经皮冠状动脉介入治疗作为血运重建策略的考量:2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南工作组的附文
Eur Heart J. 2019 Jan 7;40(2):204-212. doi: 10.1093/eurheartj/ehy532.
4
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率:一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
5
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.急性心肌梗死合并心原性休克患者的 PCI 策略。
N Engl J Med. 2017 Dec 21;377(25):2419-2432. doi: 10.1056/NEJMoa1710261. Epub 2017 Oct 30.
6
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).2017年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的冠状动脉疾病双联抗血小板治疗重点更新:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)冠状动脉疾病双联抗血小板治疗特别工作组。
Eur Heart J. 2018 Jan 14;39(3):213-260. doi: 10.1093/eurheartj/ehx419.
7
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者的抗血小板治疗降级指导(TROPICAL-ACS):一项随机、开放标签、多中心试验。
Lancet. 2017 Oct 14;390(10104):1747-1757. doi: 10.1016/S0140-6736(17)32155-4. Epub 2017 Aug 28.
8
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.缺血性心肌病患者的冠状动脉搭桥手术
N Engl J Med. 2016 Apr 21;374(16):1511-20. doi: 10.1056/NEJMoa1602001. Epub 2016 Apr 3.
9
Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.多支血管病变患者完全血运重建与不完全血运重建的结局比较:随机临床试验和观察性研究中 89883 例患者的荟萃分析。
J Am Coll Cardiol. 2013 Oct 15;62(16):1421-31. doi: 10.1016/j.jacc.2013.05.033. Epub 2013 Jun 7.